The agreement on social and economic partnership between the Pharmasyntez Group of Companies and Bratsk city administration, providing for a personal scholarship to be paid to the renowned Bratsk tobogganist in 2024, was signed on December 13 by the mayor of Bratsk Sergei Serebrennikov and Chief Executive Officer of BratskChemSyntez Ivan Dratsky.
Semyon Pavlichenko is a graduate of the "Olymp" sports school, four-time world championship medalist, six-time European champion, 2018/2019 World Cup winner, bronze medalist of the national championship.
The athlete says that part of the scholarship program will be aimed at supporting young athletes who will defend the honor of Bratsk and the country. "In early 2024, I plan to compete at the Spartakiad of the Strongest; it will be an analog of the Olympics. I thank BratskChemSyntez for their support and warm welcome, and for their care and attention," Semyon Pavlichenko said.
Sergei Serebrennikov thanked Ivan Dratsky on behalf of all Bratsk residents for invaluable moral and financial support that helps athletes keep shape and perform well at competitions. "I am grateful to the Pharmasyntez Group of Companies for the social orientation in its work. This is very good and shows that the new staff and management of the company are in our Bratsk team!", - Sergei Serebrennikov said.
"For several years now we have been supporting Alesya Kuznetsova, our famous judoka. And this year we decided to expand the scope of support. Today we have signed an Agreement with Semyon Pavlichenko, and I am sure that it is not the last one. Next year we plan to expand the program of support of the city, to increase the amount of money allocated to various infrastructure projects. We realize the importance of supporting athletes, we do realize the importance of youth development!" - Ivan Dratsky emphasized.
BratskChemSyntez LLC is one of the five manufacturing sites of the Pharmasyntez Group of Companies. It is the largest pharmaceutical complex specializing in the manufacture of active pharmaceutical ingredients that are used to make drug products: tablets, powders, and solutions for injections. The enterprise manufactures the components for the treatment of socially significant diseases such as tuberculosis, HIV, hepatitis, oncological diseases and coronavirus infection.